Main > ENDOCRINOLOGY > Diabetes Type II > Treatment > Co: UK. A. Exenatide 1/Week ER Inj*

---

Co: UK. A. Exenatide 1/Week ER Inj*'s subsections
(*) USA Approval Date: 2017. 10.23
>Suspension
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2008. 05.06
TradeMark
TradeMark Web-Site

Co: UK. A. Exenatide 1/Week ER Inj*'s products
This section has no products